(HRL) Hormel Foods - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4404521001
Stock: Meat Products, Nuts, Meals, Snacks
Total Rating 36
Risk 89
Buy Signal -0.20
| Risk 5d forecast | |
|---|---|
| Volatility | 23.9% |
| Relative Tail Risk | -6.73% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.49 |
| Alpha | -16.21 |
| Character TTM | |
|---|---|
| Beta | 0.068 |
| Beta Downside | -0.082 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.28% |
| CAGR/Max DD | -0.26 |
EPS (Earnings per Share)
Revenue
Description: HRL Hormel Foods March 05, 2026
Hormel Foods Corporation (HRL) develops, processes, and distributes meat, nuts, and other food products. The company serves foodservice, convenience store, and commercial customers domestically and internationally.
HRL operates through three segments: Retail, Foodservice, and International. The packaged foods and meats sector is characterized by both perishable and shelf-stable product offerings to diversify revenue streams. HRL offers a wide range of products, including fresh meats, frozen items, refrigerated meals, bacon, sausages, hams, and guacamole. Shelf-stable products include canned meats, nut butters, snack nuts, chili, and microwaveable meals.
HRL utilizes a multi-channel distribution model, selling products through its own sales personnel, independent brokers, and distributors. The company manages a large portfolio of brands, including HORMEL, APPLEGATE, JENNIE-O, SKIPPY, and SPAM. Understanding the performance of these individual brands can offer deeper insights into the companys market position. ValueRay provides detailed brand performance analytics to aid further research.
Hormel Foods Corporation was founded in 1891 and is headquartered in Austin, Minnesota.
Headlines to watch out for
- Meat and nut product demand impacts retail and foodservice sales
- Commodity price volatility affects input costs and margins
- International market expansion drives revenue growth
- Consumer preferences shift toward plant-based alternatives
- Supply chain disruptions increase operational expenses
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 489.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -2.31 > 1.0 |
| NWC/Revenue: 17.42% < 20% (prev 16.24%; Δ 1.18% < -1%) |
| CFO/TA 0.07 > 3% & CFO 885.3m > Net Income 489.4m |
| Net Debt (1.99b) to EBITDA (1.02b): 1.94 < 3 |
| Current Ratio: 2.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (550.7m) vs 12m ago 0.15% < -2% |
| Gross Margin: 15.53% > 18% (prev 0.17%; Δ 1536 % > 0.5%) |
| Asset Turnover: 90.90% > 50% (prev 88.88%; Δ 2.03% > 0%) |
| Interest Coverage Ratio: 9.68 > 6 (EBITDA TTM 1.02b / Interest Expense TTM 78.3m) |
Altman Z'' 4.70
| A: 0.16 (Total Current Assets 3.39b - Total Current Liabilities 1.27b) / Total Assets 13.32b |
| B: 0.57 (Retained Earnings 7.54b / Total Assets 13.32b) |
| C: 0.06 (EBIT TTM 758.0m / Avg Total Assets 13.36b) |
| D: 1.36 (Book Value of Equity 7.31b / Total Liabilities 5.36b) |
| Altman-Z'' Score: 4.70 = AA |
Beneish M -3.07
| DSRI: 0.90 (Receivables 755.1m/818.6m, Revenue 12.14b/11.91b) |
| GMI: 1.07 (GM 15.53% / 16.69%) |
| AQI: 0.97 (AQ_t 0.58 / AQ_t-1 0.59) |
| SGI: 1.02 (Revenue 12.14b / 11.91b) |
| TATA: -0.03 (NI 489.4m - CFO 885.3m) / TA 13.32b) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of HRL shares?
As of March 09, 2026, the stock is trading at USD 24.42 with a total of 2,246,365 shares traded.
Over the past week, the price has changed by -1.61%, over one month by +0.04%, over three months by +3.70% and over the past year by -15.69%.
Over the past week, the price has changed by -1.61%, over one month by +0.04%, over three months by +3.70% and over the past year by -15.69%.
Is HRL a buy, sell or hold?
Hormel Foods has received a consensus analysts rating of 3.25.
Therefor, it is recommend to hold HRL.
- StrongBuy: 1
- Buy: 1
- Hold: 10
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the HRL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 27.6 | 13.1% |
| Analysts Target Price | 27.6 | 13.1% |
HRL Fundamental Data Overview March 09, 2026
P/E Trailing = 27.4382
P/E Forward = 16.835
P/S = 1.1065
P/B = 1.6928
P/EG = 1.6431
Revenue TTM = 12.14b USD
EBIT TTM = 758.0m USD
EBITDA TTM = 1.02b USD
Long Term Debt = 2.85b USD (from longTermDebt, last quarter)
Short Term Debt = 6.49m USD (from shortTermDebt, last quarter)
Debt = 2.86b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.99b USD (from netDebt column, last quarter)
Enterprise Value = 15.39b USD (13.44b + Debt 2.86b - CCE 901.2m)
Interest Coverage Ratio = 9.68 (Ebit TTM 758.0m / Interest Expense TTM 78.3m)
EV/FCF = 26.66x (Enterprise Value 15.39b / FCF TTM 577.5m)
FCF Yield = 3.75% (FCF TTM 577.5m / Enterprise Value 15.39b)
FCF Margin = 4.76% (FCF TTM 577.5m / Revenue TTM 12.14b)
Net Margin = 4.03% (Net Income TTM 489.4m / Revenue TTM 12.14b)
Gross Margin = 15.53% ((Revenue TTM 12.14b - Cost of Revenue TTM 10.26b) / Revenue TTM)
Gross Margin QoQ = 15.51% (prev 13.96%)
Tobins Q-Ratio = 1.16 (Enterprise Value 15.39b / Total Assets 13.32b)
Interest Expense / Debt = 0.69% (Interest Expense 19.7m / Debt 2.86b)
Taxrate = 22.42% (52.5m / 234.3m)
NOPAT = 588.0m (EBIT 758.0m * (1 - 22.42%))
Current Ratio = 2.66 (Total Current Assets 3.39b / Total Current Liabilities 1.27b)
Debt / Equity = 0.36 (Debt 2.86b / totalStockholderEquity, last quarter 7.94b)
Debt / EBITDA = 1.94 (Net Debt 1.99b / EBITDA 1.02b)
Debt / FCF = 3.44 (Net Debt 1.99b / FCF TTM 577.5m)
Total Stockholder Equity = 7.99b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.66% (Net Income 489.4m / Total Assets 13.32b)
RoE = 6.13% (Net Income TTM 489.4m / Total Stockholder Equity 7.99b)
RoCE = 6.99% (EBIT 758.0m / Capital Employed (Equity 7.99b + L.T.Debt 2.85b))
RoIC = 5.42% (NOPAT 588.0m / Invested Capital 10.85b)
WACC = 5.17% (E(13.44b)/V(16.30b) * Re(6.16%) + D(2.86b)/V(16.30b) * Rd(0.69%) * (1-Tc(0.22)))
Discount Rate = 6.16% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.11%
[DCF] Terminal Value 85.06% ; FCFF base≈702.7m ; Y1≈624.1m ; Y5≈521.3m
[DCF] Fair Price = 25.06 (EV 15.78b - Net Debt 1.99b = Equity 13.79b / Shares 550.3m; r=5.90% [WACC]; 5y FCF grow -13.76% → 2.90% )
EPS Correlation: -82.78 | EPS CAGR: -8.79% | SUE: 0.54 | # QB: 0
Revenue Correlation: -15.24 | Revenue CAGR: -0.60% | SUE: -0.54 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.36 | Chg7d=+0.006 | Chg30d=+0.003 | Revisions Net=+2 | Analysts=7
EPS current Year (2026-10-31): EPS=1.48 | Chg7d=+0.011 | Chg30d=+0.011 | Revisions Net=+4 | Growth EPS=+7.7% | Growth Revenue=+1.7%
EPS next Year (2027-10-31): EPS=1.58 | Chg7d=+0.026 | Chg30d=+0.026 | Revisions Net=+3 | Growth EPS=+7.2% | Growth Revenue=+1.8%
[Analyst] Revisions Ratio: +0.50 (3 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.3% (Discount Rate 7.9% - Earnings Yield 3.6%)
[Growth] Growth Spread = -2.1% (Analyst 2.2% - Implied 4.3%)
P/E Forward = 16.835
P/S = 1.1065
P/B = 1.6928
P/EG = 1.6431
Revenue TTM = 12.14b USD
EBIT TTM = 758.0m USD
EBITDA TTM = 1.02b USD
Long Term Debt = 2.85b USD (from longTermDebt, last quarter)
Short Term Debt = 6.49m USD (from shortTermDebt, last quarter)
Debt = 2.86b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.99b USD (from netDebt column, last quarter)
Enterprise Value = 15.39b USD (13.44b + Debt 2.86b - CCE 901.2m)
Interest Coverage Ratio = 9.68 (Ebit TTM 758.0m / Interest Expense TTM 78.3m)
EV/FCF = 26.66x (Enterprise Value 15.39b / FCF TTM 577.5m)
FCF Yield = 3.75% (FCF TTM 577.5m / Enterprise Value 15.39b)
FCF Margin = 4.76% (FCF TTM 577.5m / Revenue TTM 12.14b)
Net Margin = 4.03% (Net Income TTM 489.4m / Revenue TTM 12.14b)
Gross Margin = 15.53% ((Revenue TTM 12.14b - Cost of Revenue TTM 10.26b) / Revenue TTM)
Gross Margin QoQ = 15.51% (prev 13.96%)
Tobins Q-Ratio = 1.16 (Enterprise Value 15.39b / Total Assets 13.32b)
Interest Expense / Debt = 0.69% (Interest Expense 19.7m / Debt 2.86b)
Taxrate = 22.42% (52.5m / 234.3m)
NOPAT = 588.0m (EBIT 758.0m * (1 - 22.42%))
Current Ratio = 2.66 (Total Current Assets 3.39b / Total Current Liabilities 1.27b)
Debt / Equity = 0.36 (Debt 2.86b / totalStockholderEquity, last quarter 7.94b)
Debt / EBITDA = 1.94 (Net Debt 1.99b / EBITDA 1.02b)
Debt / FCF = 3.44 (Net Debt 1.99b / FCF TTM 577.5m)
Total Stockholder Equity = 7.99b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.66% (Net Income 489.4m / Total Assets 13.32b)
RoE = 6.13% (Net Income TTM 489.4m / Total Stockholder Equity 7.99b)
RoCE = 6.99% (EBIT 758.0m / Capital Employed (Equity 7.99b + L.T.Debt 2.85b))
RoIC = 5.42% (NOPAT 588.0m / Invested Capital 10.85b)
WACC = 5.17% (E(13.44b)/V(16.30b) * Re(6.16%) + D(2.86b)/V(16.30b) * Rd(0.69%) * (1-Tc(0.22)))
Discount Rate = 6.16% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.11%
[DCF] Terminal Value 85.06% ; FCFF base≈702.7m ; Y1≈624.1m ; Y5≈521.3m
[DCF] Fair Price = 25.06 (EV 15.78b - Net Debt 1.99b = Equity 13.79b / Shares 550.3m; r=5.90% [WACC]; 5y FCF grow -13.76% → 2.90% )
EPS Correlation: -82.78 | EPS CAGR: -8.79% | SUE: 0.54 | # QB: 0
Revenue Correlation: -15.24 | Revenue CAGR: -0.60% | SUE: -0.54 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.36 | Chg7d=+0.006 | Chg30d=+0.003 | Revisions Net=+2 | Analysts=7
EPS current Year (2026-10-31): EPS=1.48 | Chg7d=+0.011 | Chg30d=+0.011 | Revisions Net=+4 | Growth EPS=+7.7% | Growth Revenue=+1.7%
EPS next Year (2027-10-31): EPS=1.58 | Chg7d=+0.026 | Chg30d=+0.026 | Revisions Net=+3 | Growth EPS=+7.2% | Growth Revenue=+1.8%
[Analyst] Revisions Ratio: +0.50 (3 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.3% (Discount Rate 7.9% - Earnings Yield 3.6%)
[Growth] Growth Spread = -2.1% (Analyst 2.2% - Implied 4.3%)